Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $422.34M.
ENTERPRISE VALUE (EV)
$422.34M
ProKidney Corp.
Market Cap
$530.88M
Enterprise Value (EV)
$422.34M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ProKidney Corp. (PROK) | $530.88M | $422.34M |
| Delcath Systems, Inc. (DCTH)vs › | $527.99M | $482.93M |
| Immix Biopharma, Inc. (IMMX)vs › | $525.25M | $300.76M |
| Nuvectis Pharma, Inc. (NVCT)vs › | $525.16M | $503.00M |
| Shattuck Labs, Inc. (STTK)vs › | $535.91M | $475.28M |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $538.80M | $523.43M |
| Monopar Therapeutics Inc. (MNPR)vs › | $539.25M | $486.60M |
| Altimmune, Inc. (ALT)vs › | $516.33M | $489.02M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $511.18M | $492.02M |
| CytomX Therapeutics, Inc. (CTMX)vs › | $554.05M | $542.53M |
Market Cap
$530.88M
Total Debt
$0.00
Cash
$108.54M
Enterprise Value
$422.34M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
